Dannielle Appelhans
About Dannielle Appelhans
Dannielle Appelhans is the Chief Operating Officer at Cour Pharmaceuticals Development Company, Inc. and a board member at Generation Bio, with extensive experience in the pharmaceutical and biotechnology industries.
Current Roles and Responsibilities
Dannielle Appelhans currently holds multiple significant positions in prominent companies in the pharmaceutical and biotechnology industries. She is the Chief Operating Officer at Cour Pharmaceuticals Development Company, Inc., where she oversees strategic and operational functions. Additionally, she serves as a Board Member at Generation Bio, contributing to the company's strategic direction and decision-making processes.
Previous Executive Leadership Experience
Previously, Dannielle Appelhans was the Chief Executive Officer at Rubius Therapeutics, a role she held from 2022 to 2023. Before this, she was the Chief Operating Officer at the same company from 2021 to 2022, based in Cambridge, Massachusetts. In these roles, she was responsible for overseeing the company's operations and strategic initiatives, demonstrating her capability in executive leadership within the biotechnology sector.
Senior Roles at Novartis
Dannielle Appelhans has held several senior leadership positions at Novartis. She served as Senior Vice President Technical Operations and Chief Technical Officer at Novartis Gene Therapies from 2020 to 2021 in the Greater Chicago Area. Prior to this, she was the Senior Vice President and Global Head of Supply Chain at Novartis from 2018 to 2020 in Basel Area, Switzerland. Her earlier roles at Novartis included Global Head Manufacturing Strategy and Operational Excellence and Global Head Operations Management for Solids and Special Technologies in Munich Area, Germany, showcasing her depth of expertise in global operations and supply chain management.
Consulting and Early Career Experience
Dannielle Appelhans also worked as a Senior Engagement Manager at McKinsey & Company from 2011 to 2014, where she provided strategic consulting services to clients particularly in the pharmaceutical sector. Furthermore, she has experience in various aspects of operations and mechanical engineering early in her career, having worked at Eli Lilly and Company in multiple roles including Senior Operations Process Team Leader and Process Engineer focusing on lyophilization processes. Additionally, she held internships at SC Johnson, Procter & Gamble, and Abbott Laboratories, providing a strong foundation for her professional development.
Educational Background
Dannielle Appelhans has a comprehensive educational background in mechanical engineering and business administration. She earned an MBA from MIT Sloan School of Management and an MS in Mechanical Engineering from the Massachusetts Institute of Technology, both from 2009 to 2011. She also holds a BS in Mechanical Engineering from the University of Michigan, completed from 2001 to 2005. This educational foundation has equipped her with the technical and managerial expertise necessary for her leadership roles in the pharmaceutical and biotechnology industries.